Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001752445-23-000001
Filing Date
2023-03-10
Accepted
2023-03-10 16:41:30
Documents
1
Effectiveness Date
2023-03-10
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8194
  Complete submission text file 0001752445-23-000001.txt   9209
Mailing Address 401 TERRY AVE N. SEATTLE WA 98109
Business Address 401 TERRY AVE N. SEATTLE WA 98109 206-732-2165
SEngine Precision Medicine, Inc. (Filer) CIK: 0001752445 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-475546 | Film No.: 23724291